Trial
NCT02458482
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
—
Condition
Asthma
Intervention
AccuPAP
Why stopped
The trainee for whom I designed the study did not begin enrollment and has left our institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-13